Evaluation of genetic enhancement: Will human wisdom properly acknowledge the value of evolution?

American Journal of Bioethics

Volumn 5, Issue 3, 2005, Pages 21-22

  Coors, Marilyn E ^a   Hunter, Lawrence ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMEDICAL AND BEHAVIORAL RESEARCH; DECISION MAKING; ETHICAL THEORY; ETHICS; EVOLUTION; GENETIC ENHANCEMENT; GENETICS AND REPRODUCTION; HUMAN; NOTE;

BIOMEDICAL AND BEHAVIORAL RESEARCH; GENETICS AND REPRODUCTION;

ETHICAL ANALYSIS; ETHICAL THEORY; EVOLUTION; GENETIC ENHANCEMENT; HUMANS; JUDGMENT;

EID: 27844514304     PISSN: 15265161     EISSN: 15360075     Source Type: Journal    
DOI: 10.1080/15265160591002683     Document Type: Note

References (9)

1. Campisi, J. 2002. Between Scylla and Charybdus: p53 links tumor suppression and aging. Mechanisms of Ageing and Development 123: 567-573.
2. Coors, M. E. 2003. The matrix: Charting an ethics of inheritable genetic modification. New York: Roman & Littlefield.
3. DePinho, R. A. 2000. The age of cancer. Nature 408: 248-254.
4. Itahana, K., G. Dimri, and J. Campisi. 2001. Regulation of cellular senescence by p53. European Journal of Biochemistry 268: 2784-2791.
5. Jonas, H. 1984. The imperative of responsibility: In search of an ethics for the technological age. Chicago: University of Chicago Press.
6. Kamm. 2005. Is There a Problem With Enhancement? The American Journal of Bioethics 5(3): 5-14.
7. Ryan, K. M., A. C. Phillips, and K. H. Voudsen. 2001. Regulation and function of the p53 tumor suppressor protein. Current Opinions in Cell Biology 13: 332-337.
8. Sandel, M., 2004. The case against perfection. The Atlantic Monthly 293(3): 51-62.
9. Tyner, S. D., S. Venkatachalam, J. Chol, et al. p53 mutant mice that display early ageing-associated phenotypes. Nature 415: 45-50.